A nasal spray that has been developed to treat life-threatening allergic reactions is now available in the UK.
Called Neffy, it offers a needle-free alternative to the EpiPen used by those at risk of potentially fatal anaphylaxis to inject themselves with adrenaline.
Research shows the spray is just as effective at stopping dangerous allergic reactions.
The first-of-its-kind product could benefit millions with severe food allergies, particularly young children, who may struggle to use an EpiPen when having a frightening reaction.
Studies also suggest that one in three people in the UK who require EpiPens fail to carry one with them when they are out, while there have been shortages of adrenaline in the past five years.
Neffy has a longer shelf-life than adrenaline injections, according to ARS Pharma, the US developer of the drug, lasting two and a half years – around double the time that current medicines can be used for.
